These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33078628)

  • 1. Alterations in drug disposition in older adults: a focus on geriatric syndromes.
    Maher D; Ailabouni N; Mangoni AA; Wiese MD; Reeve E
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):41-52. PubMed ID: 33078628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in drug disposition in older adults.
    Reeve E; Wiese MD; Mangoni AA
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):491-508. PubMed ID: 25600059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic alterations in older people with dementia.
    Reeve E; Trenaman SC; Rockwood K; Hilmer SN
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):651-668. PubMed ID: 28460576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.
    Velenosi TJ; Urquhart BL
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic alterations in the geriatric patient.
    Delafuente JC
    Consult Pharm; 2008 Apr; 23(4):324-34. PubMed ID: 18454589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy in older adults: Association Rule and Frequent-Set Analysis to evaluate concomitant medication use.
    Held F; Le Couteur DG; Blyth FM; Hirani V; Naganathan V; Waite LM; Seibel MJ; Handelsman DJ; Cumming RG; Allore HG; Gnjidic D
    Pharmacol Res; 2017 Feb; 116():39-44. PubMed ID: 27988385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutics in older adults.
    Hunter KF; Cyr D
    J Wound Ostomy Continence Nurs; 2006; 33(6):630-6; quiz 637-8. PubMed ID: 17108773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-related harm: a geriatric syndrome.
    Stevenson JM; Davies JG; Martin FC
    Age Ageing; 2019 Dec; 49(1):7-11. PubMed ID: 31665207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the clinical consequences of polypharmacy in older adults: a narrative review.
    Wastesson JW; Morin L; Tan ECK; Johnell K
    Expert Opin Drug Saf; 2018 Dec; 17(12):1185-1196. PubMed ID: 30540223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies).
    Fialová D; Laffon B; Marinković V; Tasić L; Doro P; Sόos G; Mota J; Dogan S; Brkić J; Teixeira JP; Valdiglesias V; Costa S;
    Eur J Clin Pharmacol; 2019 Apr; 75(4):451-466. PubMed ID: 30610276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Practical Guide to Geriatric Syndromes in Older Adults With Cancer: A Focus on Falls, Cognition, Polypharmacy, and Depression.
    Magnuson A; Sattar S; Nightingale G; Saracino R; Skonecki E; Trevino KM
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e96-e109. PubMed ID: 31099668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging biology and geriatric clinical pharmacology.
    McLean AJ; Le Couteur DG
    Pharmacol Rev; 2004 Jun; 56(2):163-84. PubMed ID: 15169926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting commentary--"medicines for older adults: learning from practice to develop patient centric drug products".
    Wahlich J; Stegemann S; Orlu-Gul M
    Int J Pharm; 2013 Nov; 456(1):251-7. PubMed ID: 23916726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Related Changes in Hepatic Function: An Update on Implications for Drug Therapy.
    Tan JL; Eastment JG; Poudel A; Hubbard RE
    Drugs Aging; 2015 Dec; 32(12):999-1008. PubMed ID: 26547855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions Between the Aging Gut Microbiome and Common Geriatric Giants: Polypharmacy, Frailty, and Dementia.
    Gemikonakli G; Mach J; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1019-1028. PubMed ID: 32064521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations.
    Weersink RA; Burger DM; Hayward KL; Taxis K; Drenth JPH; Borgsteede SD
    Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):45-57. PubMed ID: 31810397
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges in the management of older patients with inflammatory rheumatic diseases.
    van Onna M; Boonen A
    Nat Rev Rheumatol; 2022 Jun; 18(6):326-334. PubMed ID: 35314796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Geriatric Syndromes in the Management of Atrial Fibrillation in Older Adults: A Narrative Review.
    Alagiakrishnan K; Banach M; Mah D; Ahmed A; Aronow WS
    J Am Med Dir Assoc; 2019 Feb; 20(2):123-130. PubMed ID: 30270028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy in the Geriatric Oncology Population.
    Hersh LR; Beldowski K; Hajjar ER
    Curr Oncol Rep; 2017 Sep; 19(11):73. PubMed ID: 28942563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.